1 asset in Non-Acquired Combined Pituitary Hormone Deficiency

Therapeutic assets addressing Non-Acquired Combined Pituitary Hormone Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Setmelanotide Non-Acquired Combined Pituitary Hormone Deficiency	Rhythm Pharmaceuticals, Inc.	P3	B (60)